Intersect ENT, Inc.

Intersect ENT, Inc.verified

XENT

Price:

$28.24

Market Cap:

$0

Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in a...[Read more]

Industry

Medical - Devices

IPO Date

2014-07-24

Stock Exchange

NASDAQ

Ticker

XENT

The PE Ratio as of December 2025 (TTM) for Intersect ENT, Inc. (XENT) is -10.54

According to Intersect ENT, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -10.54. This represents a change of 63.27% compared to the average of -6.45 of the last 4 quarters.

Intersect ENT, Inc. (XENT) Historical PE Ratio (quarterly & annually)

How has XENT PE Ratio performed in the past?

The mean historical PE Ratio of Intersect ENT, Inc. over the last ten years is -20.12. The current -10.54 PE Ratio has changed 5.14% with respect to the historical average. Over the past ten years (40 quarters), XENT's PE Ratio was at its highest in in the December 2021 quarter at -2.50. The PE Ratio was at its lowest in in the June 2017 quarter at -89.15.

Quarterly (TTM)
Annual

Average

-20.12

Median

-13.71

Minimum

-57.66

Maximum

-5.69

Intersect ENT, Inc. (XENT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Intersect ENT, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 322.89%

Maximum Annual PE Ratio = -5.69

Minimum Annual Increase = -51.22%

Minimum Annual PE Ratio = -57.66

Quarterly (TTM)
Annual
YearPE RatioChange
2021-5.69-44.88%
2020-10.33-43.19%
2019-18.18-51.22%
2018-37.27-35.37%
2017-57.66322.89%
2016-13.63-38.30%
2015-22.1092.15%
2014-11.504.45%
2013-11.01-20.18%

Intersect ENT, Inc. (XENT) Average PE Ratio

How has XENT PE Ratio performed in the past?

The current PE Ratio of Intersect ENT, Inc. (XENT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-11.40

5-year avg

-25.82

10-year avg

-20.12

Intersect ENT, Inc. (XENT) PE Ratio vs. Peers

How is XENT’s PE Ratio compared to its peers?

Intersect ENT, Inc.’s PE Ratio is greater than Cardiovascular Systems, Inc. (-21.24), less than Gracell Biotechnologies Inc. (-1.61), greater than Paragon 28, Inc. (-29.28), greater than Silk Road Medical, Inc (-19.14), greater than Poseida Therapeutics, Inc. (-82.89), less than Albireo Pharma, Inc. (-5.61), less than Verve Therapeutics, Inc. (-5.46), less than Apollo Endosurgery, Inc. (-10.20), less than Harpoon Therapeutics, Inc. (-1.14), less than VectivBio Holding AG (-7.94),

Build a custom stock screener for Intersect ENT, Inc. (XENT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intersect ENT, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intersect ENT, Inc. (XENT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intersect ENT, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Intersect ENT, Inc.'s PE Ratio?

How is the PE Ratio calculated for Intersect ENT, Inc. (XENT)?

What is the highest PE Ratio for Intersect ENT, Inc. (XENT)?

What is the 3-year average PE Ratio for Intersect ENT, Inc. (XENT)?

What is the 5-year average PE Ratio for Intersect ENT, Inc. (XENT)?

How does the current PE Ratio for Intersect ENT, Inc. (XENT) compare to its historical average?